Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of strategies to reduce pain associated with etomidate injection
IRCT20160307026950N31Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of etomidate, lidocaine and melatonin (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Reduction in pain at etomidate injection site. Started Feb 2021; status: completed.
02
Drugs
etomidatelidocainemelatonin
Beyond the preview
Go deeper on IRCT20160307026950N31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N31.